Amira Pharmaceuticals

amirapharm.com

Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Our discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharma Tech

VALGENESIS AND PHARMENG TECHNOLOGY PARTNER TO MODERNIZE AND DIGITIZE VALIDATION AND COMPLIANCE FOR GLOBAL PHARMA, BIOTECH, MEDICAL DEVICE

PRNewswire | June 07, 2023

news image

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and PharmEng Technology, a global ISO-certified consulting firm focused on life sciences, have partnered to provide a range of regulatory intelligence, GxP compliance, and digitized validation solutions for pharmaceutical, biotechnology, medical device, and nutraceutical companies across the globe. PharmEng Technology has staff all over the world serving companies of all sizes, prov...

Read More

Research

GENSCRIPT RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR WORLD'S FIRST SARS-COV-2 NEUTRALIZING ANTIBODY DETECTION KIT

GenScript | November 09, 2020

news image

GenScript USA Inc., the world's leading research reagent provider, announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. This is the first commercially available test to specifically detect neutralizing antibodies without the use of live virus. Neutralizing antibodies, a subset of antibodies that are specifically able to block the ability of the virus to enter a cel...

Read More

Pharmacy Market

CASI PHARMACEUTICALS ANNOUNCES CNCT19 (CD19 CAR-T) GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA

CASI Pharmaceuticals, Inc. | January 19, 2022

news image

CASI Pharmaceuticals, Inc. a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced today, that the U.S. Food and Drug Administration as granted Orphan Drug Designation for CNCT19, an investigational CD-19 directed CAR-T therapy, for the treatment of patients with Acute Lymphoblastic Leukemia. CNCT19 is currently being developed independently by Juventas to meet the urgent clinical needs of pati...

Read More

Pharmacy Market

VERIX ACQUIRES START-UP.AI, FURTHER ENHANCING ITS CAPABILITIES TO LEVERAGE THE POWER OF AI TO ACCELERATE BRAND GROWTH FOR LIFE SCIENCE COMPANIES

PRNewswire | June 16, 2023

news image

Verix, the leading provider of Tovana, an AI driven commercial optimization platform for the pharmaceutical industry, announced that it has acquired start-up.ai, a team of AI specialists that helps businesses improve their processes using artificial intelligence and machine learning. The start-up.ai team will be fully integrated into Verix's AI lab, with Shahar Cohen, start-up.ai's co-founder and CEO, to serve as Verix's CTO. Pharmaceutical companies currently often ...

Read More
news image

Pharma Tech

VALGENESIS AND PHARMENG TECHNOLOGY PARTNER TO MODERNIZE AND DIGITIZE VALIDATION AND COMPLIANCE FOR GLOBAL PHARMA, BIOTECH, MEDICAL DEVICE

PRNewswire | June 07, 2023

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and PharmEng Technology, a global ISO-certified consulting firm focused on life sciences, have partnered to provide a range of regulatory intelligence, GxP compliance, and digitized validation solutions for pharmaceutical, biotechnology, medical device, and nutraceutical companies across the globe. PharmEng Technology has staff all over the world serving companies of all sizes, prov...

Read More
news image

Research

GENSCRIPT RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR WORLD'S FIRST SARS-COV-2 NEUTRALIZING ANTIBODY DETECTION KIT

GenScript | November 09, 2020

GenScript USA Inc., the world's leading research reagent provider, announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit. This is the first commercially available test to specifically detect neutralizing antibodies without the use of live virus. Neutralizing antibodies, a subset of antibodies that are specifically able to block the ability of the virus to enter a cel...

Read More
news image

Pharmacy Market

CASI PHARMACEUTICALS ANNOUNCES CNCT19 (CD19 CAR-T) GRANTED ORPHAN DRUG DESIGNATION BY THE U.S. FDA

CASI Pharmaceuticals, Inc. | January 19, 2022

CASI Pharmaceuticals, Inc. a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced today, that the U.S. Food and Drug Administration as granted Orphan Drug Designation for CNCT19, an investigational CD-19 directed CAR-T therapy, for the treatment of patients with Acute Lymphoblastic Leukemia. CNCT19 is currently being developed independently by Juventas to meet the urgent clinical needs of pati...

Read More
news image

Pharmacy Market

VERIX ACQUIRES START-UP.AI, FURTHER ENHANCING ITS CAPABILITIES TO LEVERAGE THE POWER OF AI TO ACCELERATE BRAND GROWTH FOR LIFE SCIENCE COMPANIES

PRNewswire | June 16, 2023

Verix, the leading provider of Tovana, an AI driven commercial optimization platform for the pharmaceutical industry, announced that it has acquired start-up.ai, a team of AI specialists that helps businesses improve their processes using artificial intelligence and machine learning. The start-up.ai team will be fully integrated into Verix's AI lab, with Shahar Cohen, start-up.ai's co-founder and CEO, to serve as Verix's CTO. Pharmaceutical companies currently often ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us